# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Matt Miksic maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $374 to $402.
Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $364 to...
Needham analyst Mike Matson maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $392 to $393.
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $372 to $360.
Stifel analyst Rick Wise maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $375 to $365.
UBS analyst Danielle Antalffy maintains Stryker (NYSE:SYK) with a Neutral and raises the price target from $351 to $366.
RBC Capital analyst Shagun Singh reiterates Stryker (NYSE:SYK) with a Outperform and maintains $386 price target.
2024 OutlookBased on our year-to-date performance and our positive outlook related to sustained procedural volumes and a health...